Wilmington Pharmaceuticals

OverviewSuggest Edit

Wilmington Pharmaceuticals is a company developing patient-friendly, fast-dissolving formulations for established medicines. It utilizes Catalent Pharma Solutions' Zydis technology for use in Metozolv ODT (metoclopramide) and development of products in pain and the central nervous system.
TypePrivate
Founded2002
Websitewilmingtonpharma.com
Overall CultureB+

Latest Updates

Employees (est.) (May 2020)3(+200%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Wilmington Pharmaceuticals

Eugene T. Haley

Eugene T. Haley

Chief Executive Officer and Founder
Thomas J. Aluise

Thomas J. Aluise

Chief Financial Officer
David A. Burns R.ph

David A. Burns R.ph

Vice President, Development and Manufacturing
Show more

Wilmington Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2002

Wilmington Pharmaceuticals total Funding

$1.3 m

Wilmington Pharmaceuticals latest funding size

$1.3 m

Time since last funding

15 years ago
Wilmington Pharmaceuticals's latest funding round in October 2006 was reported to be $1.3 m. In total, Wilmington Pharmaceuticals has raised $1.3 m
Show all financial metrics

Wilmington Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Wilmington Pharmaceuticals Online and Social Media Presence

Embed Graph

Wilmington Pharmaceuticals Company Culture

  • Overall Culture

    B+

    82/100

  • CEO Rating

    A+

    80/100

  • Compensation

    A+

    100/100

Learn more on Comparably

Wilmington Pharmaceuticals Frequently Asked Questions

  • When was Wilmington Pharmaceuticals founded?

    Wilmington Pharmaceuticals was founded in 2002.

  • Who are Wilmington Pharmaceuticals key executives?

    Wilmington Pharmaceuticals's key executives are Eugene T. Haley, Thomas J. Aluise and David A. Burns R.ph.

  • How many employees does Wilmington Pharmaceuticals have?

    Wilmington Pharmaceuticals has 3 employees.

  • Who are Wilmington Pharmaceuticals competitors?

    Competitors of Wilmington Pharmaceuticals include Alembic Pharmaceuticals, EMS Pharma and Livzon Pharmaceutical Group.